Indication
Death
7 clinical trials
10 products
1 drug
Clinical trial
A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe Chronic Kidney DiseaseStatus: , Estimated PCD: 2027-01-01
Product
DapagliflozinProduct
PlaceboClinical trial
Comparative Study of Propofol Versus Dexmedetomidine for Conscious Sedation During Transcatheter Aortic Valve ImplantationStatus: Recruiting, Estimated PCD: 2024-11-15
Product
PropofolProduct
DexmedetomidineClinical trial
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial FibrillationStatus: Recruiting, Estimated PCD: 2025-12-01
Product
ApixabanClinical trial
A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients (The TARGET-D Study)Status: Active (not recruiting), Estimated PCD: 2023-05-03
Drug
Vitamin D3Clinical trial
Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan ChildrenStatus: Active (not recruiting), Estimated PCD: 2020-05-04
Product
AzithromycinClinical trial
Randomized Trial Evaluating the Non-specific Effects of Different BCG Strains in Guinea-Bissau: Effects on Early-life Mortality and MorbidityStatus: Completed, Estimated PCD: 2022-10-30
Product
BCG-JapanProduct
BCG-RussiaClinical trial
Randomized Trial Evaluating the Non-specific Effects of BCG-Bulgaria and BCG-Denmark in Guinea-Bissau: Effects on Mortality, Morbidity, and BCG Skin ReactionsStatus: Recruiting, Estimated PCD: 2024-07-01
Product
BCG-DenmarkProduct
BCG-Bulgaria